The rationale to screen for glucose-6-phosphate dehydrogenase (G6PD) deficiency in HIV-infected individuals is their increased likelihood to receive oxidant drugs and subsequent potential of hemolytic events. However, current guidelines regarding who should be screened are conflicting. The authors examined the prevalence of G6PD deficiency and the frequency of hemolytic events in an urban HIV clinic. They used data from a military database as a comparison. In both cohorts, a relatively high number of black females were found to be G6PD deficient (10% and 13%), which was similar to the rate in men (15% and 12%). No white females were G6PD deficient. The authors identified 8 drug-related hemolytic events in HIV clinic patients. Two patients necessitated blood transfusions; both were triggered by trimethoprim/sulfamethoxazole (TMP/SMX). Although G6PD screening prior to the use of TMP/SMX is not often considered by clinicians, the authors' finding of 2 hemolytic events requiring transfusion suggests this would be beneficial.
Uddin DE, Dickson LG, Brodine CEGlucose-6-phosphate dehydrogenase deficiency in military recruits. JAMA. 1974; 227(12):1408-1409.
2.
Butler T.G-6-PD deficiency and malaria in black Americans in Vietnam. Mil Med. 1973;138(3):153-155.
3.
Petrakis NL, Wiesenfeld SL, Sams BJ, Collen MF, Cutler JL, Siegelaub ABPrevalence of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency . N Engl J Med. 1970; 282(14):767-770.
4.
Heller P., Best WR, Nelson RB, Becktel J.Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med . 1979;300(18):1001-1005.
5.
Chinevere TD , Murray CK, Grant E. Jr, Johnson GA, Duelm F., Hospenthal DRPrevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel. Mil Med. 2006; 171(9):905-907.
6.
Kaplan JE, Masur H., Holmes KKGuidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep.2002;51(RR-8):1-52.
7.
Gordon CM, Forsyth AD, Stall R., Cheever LWPrevention interventions with persons living with HIV/AIDS: state of the science and future directions. AIDS Educ Prev.2005 ; 17(1 Suppl A):6-20.
8.
Bartlett JG, Gallant JE2005-2006 Medical Management of HIV Infection. Baltimore , MD: Johns Hopkins Medicine Health Publishing Group ; 2005.
Aberg JA, Gallant JE, Anderson J., et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004;39(5):609-629.
